Physician profile
Chi Lee
NPI 1194883769
$7,180.25
in general payments reported to CMS, 2019-2025
41 companies · $1,644 in 2025
The $1,644 reported for 2025 was more than what 95% of Pediatric Urology providers received nationally (typical 2025 total: $127).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $891 · 2020: $439 · 2021: $911 · 2022: $1,203 · 2023: $929 · 2024: $1,163 · 2025: $1,644.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,668 · Education: $68.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,668.01 |
| Education | $68.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,285.29 | 2019-2025 | Erleada, Carvykti, Rybrevant |
| Astellas Pharma US INC | $1,044.90 | 2019-2025 | Myrbetriq, Xtandi, Veozah |
| Abbvie INC. | $568.48 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $502.71 | 2023-2025 | Gemtesa, Orgovyx |
| Amgen INC. | $407.16 | 2019-2023 | Xgeva |
| Accord Healthcare, INC. | $290.14 | 2024-2025 | |
| Dendreon Pharmaceuticals LLC | $274.83 | 2019-2023 | Provenge |
| Pfizer INC. | $256.95 | 2019-2025 | |
| Ferring Pharmaceuticals INC. | $241.63 | 2019-2025 | Adstiladrin |
| Verity Pharmaceuticals INC. | $176.95 | 2024-2025 | Trelstar, Tlando |
| Urogen Pharma, INC. | $168.86 | 2022-2025 | Jelmyto |
| Myovant Sciences INC. | $144.62 | 2021-2022 | |
| Blue Earth Diagnostics | $135.02 | 2019-2022 | |
| Procept Biorobotics Corporation | $130.76 | 2019-2025 | Aquabeam System |
| Endo USA, INC. | $128.74 | 2024-2025 | Xiaflex |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chi Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.